DK MedTech and Mozarc Medical Announce Strategic Partnership for U.S. Market to Advance Vascular Access Care in Hemodialysis

Founder and CEO of DK Medtech, Weng YulinSaid, "The cooperation with Mozarc is an important springboard for DK Medtech's globalization. With our original technology honed over a decade, we are providing 'China's answer' to the field of hemodialysis."

Ven Manda, CEO of Mozarc MedicalEmphasized: "This collaboration will benefit more than 500,000 dialysis patients in the U.S. The addition of DKutting™ and DKaptain™ will strengthen our renal vascular access treatment solutions, jointly advancing the standard of dialysis care for patients."

Mozarc Medical will become part of DK Medtech.DKutting™ High-Pressure Scoring BalloonAndDKaptain™ High-Pressure Balloon CatheterThe exclusive promotion and sales partner for two products in the U.S. market, jointly advancing clinical treatment in the hemodialysis access field.

DKutting™ High-Pressure Scoring Balloon: CombiningDirectional Cutting and High-Pressure ExpansionThe capable balloon product, with its exclusive scoring design, can precisely address high-resistance calcified lesions while minimizing vascular injury.

DKaptain™ High-Pressure Balloon Catheter: Specifically designed forComplex Vascular LesionsDesign, Possess26atm Ultra-High Burst Pressure, suitable for vessel diameters ranging from 3.0mm to 12.0mm, covering the full range of clinical needs.